I.F. Gazi

468 citations

9 papers · 402 indexed · h-index 9

Co-authors: Moses Elisaf Theodosios D. Filippatos Alexandros D. Tselepis Dimitrios N. Kiortsis Evangelos Liberopoulos Konstantinos Lagos A. Tselepis Christos S. Derdemezis
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers)Paraoxonase enzyme and polymorphisms (3 papers)Lipoproteins and Cardiovascular Health (3 papers)
Cited by: Endocrinology, Diabetes and Metabolism Clinical Biochemistry Endocrine and Autonomic Systems
Journals: Journal of Lipid Research Atherosclerosis Diabetes Obesity and Metabolism
Partner nations: Greece United Kingdom

In The Last Decade

I.F. Gazi

9 papers receiving 390 citations

Peers

Countries citing papers authored by I.F. Gazi

Since Specialization

Citations

This map shows the geographic impact of I.F. Gazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.F. Gazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.F. Gazi more than expected).

Fields of papers citing papers by I.F. Gazi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.F. Gazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.F. Gazi. The network helps show where I.F. Gazi may publish in the future.

Co-authorship network of co-authors of I.F. Gazi

This figure shows the co-authorship network connecting the top 25 collaborators of I.F. Gazi. A scholar is included among the top collaborators of I.F. Gazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.F. Gazi. I.F. Gazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile 2011 ·Nutrition Metabolism and Cardiovascular Diseases ·Theodosios D. Filippatos,Vasilis Tsimihodimos,Christos S. Derdemezis,I.F. Gazi,(unknown),D.P. Mikhailidis,Alexandros D. Tselepis,Moses Elisaf	22
2	Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes 2010 ·Atherosclerosis ·(unknown),I.F. Gazi,Konstantinos Lagos,(unknown),Alexandros D. Tselepis,Evangelos Liberopoulos,Moses Elisaf	38
3	Persistence of an atherogenic lipid profile after treatment of acute infection with brucella 2009 ·Journal of Lipid Research ·(unknown),I.F. Gazi,Angeliki Kostoula,Constantinos C. Tellis,A. Tselepis,Moses Elisaf,Evangelos Liberopoulos	34
4	Alterations in the High Density Lipoprotein Phenotype and HDL‐Associated Enzymes in Subjects with Metabolic Syndrome 2008 ·Lipids ·Konstantinos Lagos,Theodosios D. Filippatos,Vasilis Tsimihodimos,I.F. Gazi,Christos V. Rizos,Alexandros D. Tselepis,Dimitri P. Mikhailidis,Moses Elisaf	59
5	The effects of orlistat and fenofibrate, alone or in combination, on high‐density lipoprotein subfractions and pre‐beta1‐HDL levels in obese patients with metabolic syndrome 2007 ·Diabetes Obesity and Metabolism ·Theodosios D. Filippatos,Evangelos Liberopoulos,Michael S. Kostapanos,I.F. Gazi,Eleni C. Papavasiliou,Dimitrios N. Kiortsis,Alexandros D. Tselepis,Moses Elisaf	46
6	Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease 2007 ·International Journal of Clinical Practice ·G. Vrentzos,John A. Papadakis,Emmanuel S. Ganotakis,Kosmas I. Paraskevas,I.F. Gazi,Νikolaos Tzanakis,D.R. Nair,D.P. Mikhailidis	14
7	Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. 2007 ·PubMed ·I.F. Gazi,(unknown),Mikhailidis Dp,Emmanuel S. Ganotakis	34
8	Increased plasma visfatin levels in subjects with the metabolic syndrome 2007 ·European Journal of Clinical Investigation ·Theodosios D. Filippatos,Christos S. Derdemezis,I.F. Gazi,Konstantinos Lagos,Dimitrios N. Kiortsis,A. Tselepis,Moses Elisaf	76
9	The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome 2006 ·Atherosclerosis ·Theodosios D. Filippatos,I.F. Gazi,Evangelos Liberopoulos,Vasilios G. Athyros,Moses Elisaf,Alexandros D. Tselepis,Dimitrios N. Kiortsis	79

About I.F. Gazi

I.F. Gazi is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 9 papers that have together received 402 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Paraoxonase enzyme and polymorphisms (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (156 citations), Clinical Biochemistry (34 citations) and Endocrine and Autonomic Systems (28 citations). I.F. Gazi has collaborated with scholars based in Greece and United Kingdom. Frequent co-authors include Moses Elisaf, Theodosios D. Filippatos, Alexandros D. Tselepis, Dimitrios N. Kiortsis, Evangelos Liberopoulos, Konstantinos Lagos, A. Tselepis, Christos S. Derdemezis, Vasilios G. Athyros and Vasilis Tsimihodimos. Their work appears in journals such as Journal of Lipid Research, Atherosclerosis and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact